Center For Health ציבורי
[search 0]
עוד

Download the App!

show episodes
 
Loading …
show series
 
Welcome back to Parasites: The Mystery of Stealth Proteins! In Part 2 of this podcast, Victoria and Well of Life Center Owner and Critical Care Clinician, Cynthia Hofmann-Coale continue their discussion about stealth proteins.על ידי Well of Life Center
 
In episode 4 part 1, Victoria is joined once again by Well of Life Center Owner and Critical Care Clinician, Cynthia Hofmann-Coale, to discuss parasites and the sudden popularity of the topic among health influencers and what the truth behind the mystery of stealth proteins really is. Make sure not to miss Part 2 of this conversation coming soon.…
 
In episode 3, Victoria is joined by Well of Life Center Owner and Critical Care Clinician, Cynthia Hofmann-Coale, to discuss fad diets and why they don’t work long term and how lifestyle changes can better impact your health and weight.על ידי Well of Life Center
 
In Part 2 of Healthy Beginnings Victoria continues her discussion on how to jumpstart your journey to better health with simple changes you can make around your home and kitchen. In episode 2, Victoria discusses why you should limit your exposure to plastics and aluminum foil, popular home cleaning and health and beauty products, and other products…
 
In the 1st episode of our podcast, Healthy Beginnings Part 1, Victoria shares some simple tips and tools on how to get started on your journey toward better health. She shares some simple first steps to help get you to the 1st level of healing and start getting your body into a better state of health. In this episode Victoria covers the kitchen and…
 
Harry is a 72-year-old with diabetes and hypertension but no primary event with LDL-C 110 mg/dL and 1-year ASCVD risk score of 43%. Although he is a candidate for high-intensity statin therapy, atorvastatin 10 mg daily is the highest dose he tolerates.על ידי Annenberg Center for Health Sciences
 
Anisa is a 54-year-old with hypertension and stage 3 chronic kidney disease (but not diabetes mellitus) and LDL-C <190 mg/dL despite high-intensity statin therapy. Results of clinical trials show that reducing atherogenic lipoproteins to very low levels (LDL-C <50 mg/dL) is beneficial in reducing the risk of a cardiovascular event compared to highe…
 
Jessica is a 24-year-old with heterozygous familial hypercholesterolemia with LDL-C hyperlipidemia despite high-intensity statin therapy. The benefits and limitations of the addition of ezetimibe or a PCSK9 inhibitor are discussed.על ידי Annenberg Center for Health Sciences
 
Mateo is a 68-year-old male treated with moderate-intensity statin therapy who needs treatment intensification for secondary prevention. Treatment options are discussed based on clinical trials such as IMPROVE-IT, ODYSSEY Long Term, FOURIER, and GLAGOV.על ידי Annenberg Center for Health Sciences
 
Patients who receive a prescription for statin therapy often remain at increased cardiovascular risk due to elevated low-density lipoprotein cholesterol (LDL-C). Organizations such as the American College of Cardiology, American Heart Association, and National Lipid Association have developed algorithms to guide the management of patients with LDL-…
 
Loading …

מדריך עזר מהיר

זכויות יוצרים 2022 | מפת אתר | מדיניות פרטיות | תנאי השירות
Google login Twitter login Classic login